J Oglobine

418 total citations
13 papers, 328 citations indexed

About

J Oglobine is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, J Oglobine has authored 13 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in J Oglobine's work include Protease and Inhibitor Mechanisms (7 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). J Oglobine is often cited by papers focused on Protease and Inhibitor Mechanisms (7 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). J Oglobine collaborates with scholars based in France, United Kingdom and Canada. J Oglobine's co-authors include K. Hacène, C. Bouchet, Antonio Gentile, F. Spyratos, Véronique Becette, Frédérique Spyratos, A Desplaces, S. Lasry, Pierre‐Marie Martin and M. Tubiana-Hulin and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

J Oglobine

13 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Oglobine France	9	259	140	111	92	82	13	328
C. Bouchet France	9	309 1.2×	202 1.4×	116 1.0×	127 1.4×	87 1.1×	16	403
F. Spyratos France	8	206 0.8×	223 1.6×	55 0.5×	110 1.2×	52 0.6×	25	391
J Geurts-Moespot Netherlands	7	219 0.8×	168 1.2×	60 0.5×	142 1.5×	38 0.5×	9	330
Kelly Yan United States	2	122 0.5×	71 0.5×	76 0.7×	163 1.8×	147 1.8×	3	385
Mehdi El Hour Belgium	5	127 0.5×	127 0.9×	83 0.7×	174 1.9×	46 0.6×	5	345
Aaron Sabbota United States	7	188 0.7×	260 1.9×	48 0.4×	155 1.7×	44 0.5×	11	424
Mercia Medeiros Pacheco Brazil	11	162 0.6×	176 1.3×	41 0.4×	159 1.7×	30 0.4×	15	422
Eian Caulder United States	7	58 0.2×	236 1.7×	54 0.5×	192 2.1×	83 1.0×	11	385
M. Ferrero-Poüs France	8	231 0.9×	228 1.6×	29 0.3×	112 1.2×	28 0.3×	10	432
Brenda L. Petrella United States	9	242 0.9×	159 1.1×	39 0.4×	231 2.5×	27 0.3×	11	431

Countries citing papers authored by J Oglobine

Since Specialization

Citations

This map shows the geographic impact of J Oglobine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Oglobine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Oglobine more than expected).

Fields of papers citing papers by J Oglobine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Oglobine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Oglobine. The network helps show where J Oglobine may publish in the future.

Co-authorship network of co-authors of J Oglobine

This figure shows the co-authorship network connecting the top 25 collaborators of J Oglobine. A scholar is included among the top collaborators of J Oglobine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Oglobine. J Oglobine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Soulié, P, Mélanie Héroult, Isabelle Bernard‐Pierrot, et al.. (2004). Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients. Cancer Detection and Prevention. 28(5). 319–324. 15 indexed citations

Bouchet, C., K. Hacène, Patrick Martin, et al.. (2000). [Breast cancer: prognostic value of a dissemination index based on 4 components of the urokinase-type plasminogen activator system].. PubMed. 48(9). 825–31. 2 indexed citations

Bouchet, C., K. Hacène, Pierre‐Marie Martin, et al.. (1999). Dissemination Risk Index Based on Plasminogen Activator System Components in Primary Breast Cancer. Journal of Clinical Oncology. 17(10). 3048–3057. 58 indexed citations

Bouchet, C., et al.. (1998). Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods. British Journal of Cancer. 77(9). 1495–1501. 14 indexed citations

Spyratos, Frédérique, et al.. (1996). Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues. Breast Cancer Research and Treatment. 41(2). 141–146. 11 indexed citations

Romain, S, et al.. (1995). Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissues.. PubMed. 33(9). 603–8. 8 indexed citations

Bouchet, C., et al.. (1994). Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. British Journal of Cancer. 69(2). 398–405. 137 indexed citations

Bouchet, C., et al.. (1994). [Prognostic value of urokinase-type plasminogen activator and 2 inhibitors PAI-1 and PAI-2 in breast cancer].. PubMed. 81(9). 770–9. 4 indexed citations

Bouchet, C., K. Hacène, N Pourreau-Schneider, et al.. (1991). Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours. British Journal of Cancer. 64(5). 926–932. 42 indexed citations

10.

Powles, T.J., S. Ashley, Alwynne Tidy, et al.. (1991). Timing of surgery in breast cancer. The Lancet. 337(8757). 1603–1605. 15 indexed citations

11.

Lidereau, Rosette, F. Spyratos, Marie‐Claude Renaud, J Oglobine, & A Desplaces. (1986). Prognostic Value of Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) Content of Human Breast Carcinomas: Correlation with Clinical and Histologic Features and Hormone Receptors. Annals of the New York Academy of Sciences. 464(1). 531–533. 1 indexed citations

12.

Spyratos, F., J Oglobine, Rosette Lidereau, et al.. (1986). Tissue glycolytic enzymes in primary breast cancer patients receiving adjuvant chemotherapy. European Journal of Cancer and Clinical Oncology. 22(1). 21–27. 3 indexed citations

13.

Hacène, K., et al.. (1986). Competitive prognostic value of clinicopathologic and bioimmunologic factors in primary breast cancer. Cancer. 57(2). 245–250. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact